commence

Neogenix Oncology, Inc. (Neogenix) announced that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns...

Okay so i just need to tell you all this because it made me so angry. So i was walking to class and i feel my backpack move a little and i reach my hand to the back and i feel that one of my pockets are open and i hear giggling and i'm like, okay if one of these immature little freshman girls...